Some more: Does anyone know what a "KOL" is? Sounds

New Post Public Reply Private Reply Replies (1) Message Board
Bravo16
316
Some more: Does anyone know what a "KOL" is?

Sounds like a spokesperson of sorts and the way Joe describes it here is that the ones he uses are doing it essentially for free because they know how good GNBT's the science

Joseph Moscato

only people to me are KOLS I listen to, academia is never something a drug developer like myself or my peers would ever take seriously, listen to, and even consider, and that’s just the way it is, if it’s cancer I want to know all the drugs you’ve been part of developing, does not matter if they have been commercialized or not, what matters is that clinician being on the front line and have participated because of their knowledge in all drug trials, why, they have the knowledge in the pathway, they have the experience and know what works and what doesn’t in regard to mechanism of action without them you got nothing, a KOL also gets paid an honorarium of about 1,500.00 a year and his expenses paid to go to conferences and talk you up and represent the science, if you have the best of the best on your team for this you know they believe in your science and they want to be part of the next big thing, then there is those same kols if the get paid big money or consideration that tells you something else, it means they are not sure about your science and want to be compensated for their time because it won’t probably be the next big thing, then their are the experts or supposed experts with big names that aren’t in let’s say breast cancer but the biggest in another area, or their a surgeon, big red flag that means they make a lot and your science is garbage, in addition as it pertains the the best surgeons on the planet you see one of them in science for sure they are getting paid big, huge red flag, why would a drug developer have a surgeon on board, cause they don’t know the business, that’s never taken seriously in fact it’s a joke, surgeons cut things out, they do not treat so why are they in drug development, because of the almighty dollar and lack of knowledge of the companies management team, the goal is always to partner with big pharma when the time is right and these signals will get your thrown out an office rather then sit down let’s discuss your science, so no I do not take any kind of Dr’s word or hyperbole who is not a KOL in the field you are developing that drug in, I just normally laugh!

Jay Colavita

I'm impressed with the explanation about the distinction of whether the opinion is actually factual or monetary driven. Everyone has an opinion and some are assholes and stink! I know you and you demand exceptional accomplishments only surrounding yourself with the best. I have faith under your direction your team will provide the best long term solution to this dilemma.

Joseph Moscato yes and we do have the best in my humble opinion

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tom Doyle Takes Helm at Gallagher's HR Consulting

Updated Category News Views 158

Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...

Continue Reading
Stellus Capital Set to Unveil Q3 Results: Key Details

Updated Category News Views 34

Stellus Capital's Upcoming Financial Reveal: Stakes and Details November's not just bringing the cold breezes, folks; it's also ushering in the much-anticipated financial digits of Stellus Capital Investment Corporation's third quarter of 2026. Mark your calendars for November 9, after the stock market wraps up, when Stellus will drop its operational performance stats for...

Continue Reading
Orbital 2.0: A Game-Changer for Energy Operations

Updated Category News Views 47

Revolutionising Energy Systems with AI Some days, tech companies sling buzzwords like they're going out of style. But when Applied Computing dropped Orbital 2.0 at ADIPEC 2026, it seemed like there might be something solid behind the chatter. The updated AI system doesn't just crunch data—it learns the ins and outs of the actual processes keeping energy plants humming....

Continue Reading
Edible Oils: Market Growth, Trends, and Investments

Updated Category News Views 146

Riding the Edible Oil Wave The edible oils market seems to be gearing up for a steady rise. Folks, the numbers are speaking loud and clear. We're looking at the market booming from USD 277.74 billion in 2026 to a hefty USD 351.08 billion in 2031. According to MarketsandMarkets™, a compound annual growth rate (CAGR) of 4.8% is on the cards. Now, if that doesn't get the...

Continue Reading
Ravi Bhalla Snags Top Franchise Award with $5M Milestone

Updated Category News Views 62

From Local Fixture to National Recognition Ravi Bhalla, owner of PostalAnnex #16006 in Calabasas, CA, takes home the Crystal Award at Annex Brands' 2026 National Convention in Vegas. And let me tell you, this isn't just some shiny trophy to stuff in a display case. This is major. Shattering Sales Goals What's the big kerfuffle over? It's this: Bhalla cracked the $5...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 70

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
Drone Tech Transforms Polish Mountain Rescues

Updated Category News Views 81

Innovation Meets Mountains You think search and rescue is all dog teams and heroic treks? Think again. Poland's mountain rescue team, known as TOPR, is flipping the script. Nestled in the rugged Tatra Mountains, they're leading a drone tech revolution that's shifting the game entirely. Drones: From Base to Peak in Minutes TOPR's team isn't just experimenting; they've...

Continue Reading
Marc Majors Takes Helm as GESMN Service Chief

Updated Category News Views 22

Marc Majors: Leading the Charge at GESMN Every now and then, an organization gets a shot of adrenaline that could redefine its path—or so they hope. Marc Majors stepping into the role of Chief Services & Programs Officer at Goodwill-Easter Seals Minnesota (GESMN) might just be one of those moments. This isn't just a title transfer. It's a whole strategic shift, folks....

Continue Reading
Curaleaf Eyes Aurora Amid Alternative from Organigram

Updated Category News Views 65

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

Continue Reading
Goodal Skincare Capitalizes on K-Beauty Craze at Costco

Updated Category News Views 113

A Venture into American Retail Goodal, the darling of Korea's skincare scene, is staking its claim at Costco. This is no small feat, my friends. We're talkin' about a brand that's carved out a sweet niche with its Green Tangerine line. Now it's hitching its wagon to one of America's retail behemoths, known for its unique knack in beauty products. From Olive Young to...

Continue Reading
lass="blog__more"> More News Articles